Related Experiment Video
Updated: Dec 15, 2025
Comparison of Three Different Methods for Determining Cell Proliferation in Breast Cancer Cell Lines
Published on: September 3, 2016
Proliferative Classification of Intracranially Injected HER2-positive Breast Cancer Cell Lines
Yuka Kuroiwa1, Jun Nakayama1, Chihiro Adachi1
1Department of Life Science and Medical Bioscience, School of Advanced Science and Engineering, Waseda University, TWIns 2-2 Wakamatsu-cho, Shinjuku-ku, Tokyo 162-8480, Japan.
Abstract:
HER2 is overexpressed in 25-30% of breast cancers, and approximately 30% of HER2-positive breast cancers metastasize to the brain. Although the incidence of brain metastasis in HER2-positive breast cancer is high, previous studies have been mainly based on cell lines of the triple-negative subtype, and the molecular mechanisms of brain metastasis in HER2-positive breast cancer are unclear. In the present study, we performed intracranial injection using nine HER2-positive breast cancer cell lines to evaluate their proliferative activity in brain tissue. Our results show that UACC-893 and MDA-MB-453 cells rapidly proliferated in the brain parenchyma, while the other seven cell lines moderately or slowly proliferated. Among these nine cell lines, the proliferative activity in brain tissue was not correlated with either the HER2 level or the HER2 phosphorylation status. To extract signature genes associated with brain colonization, we conducted microarray analysis and found that these two cell lines shared 138 gene expression patterns. Moreover, some of these genes were correlated with poor prognosis in HER2-positive breast cancer patients. Our findings might be helpful for further studying brain metastasis in HER2-positive breast cancer.
Insights
This study investigated brain metastasis in HER2-positive breast cancer. Researchers identified specific cell lines that proliferate in the brain, revealing gene expression patterns linked to poor prognosis in patients.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Metastasis
Background:
- HER2 overexpression occurs in 25-30% of breast cancers.
- Approximately 30% of HER2-positive breast cancers lead to brain metastasis.
- Molecular mechanisms of brain metastasis in HER2-positive breast cancer are not well understood, with limited research on relevant cell lines.
Purpose of the Study:
- To evaluate the proliferative activity of HER2-positive breast cancer cell lines in brain tissue.
- To identify molecular signatures associated with brain colonization in HER2-positive breast cancer.
- To understand the mechanisms underlying brain metastasis in this patient subgroup.
Main Methods:
- Intracranial injection of nine HER2-positive breast cancer cell lines in mice.
- Assessment of cell proliferation within the brain parenchyma.
- Microarray analysis to identify shared gene expression patterns in highly proliferative cell lines.
Main Results:
- UACC-893 and MDA-MB-453 cell lines demonstrated rapid proliferation in the brain.
- Proliferative activity in the brain was not correlated with HER2 expression levels or phosphorylation status.
- A shared set of 138 gene expression patterns was identified in the two rapidly proliferating cell lines.
Conclusions:
- Specific HER2-positive breast cancer cell lines exhibit distinct abilities for brain colonization.
- Identified gene expression patterns may serve as biomarkers for brain metastasis and prognosis in HER2-positive breast cancer.
- Findings provide a foundation for further research into the molecular mechanisms of brain metastasis in HER2-positive breast cancer.
